Moderna, Inc.
MRNA
$125.59
$14.1312.68%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 6.67B | 8.74B | 10.10B | 14.34B | 18.44B |
| Total Other Revenue | 177.00M | 384.00M | 554.00M | 721.00M | 828.00M |
| Total Revenue | 6.85B | 9.12B | 10.65B | 15.06B | 19.26B |
| Cost of Revenue | 9.54B | 10.33B | 8.85B | 9.06B | 8.71B |
| Gross Profit | -2.69B | -1.21B | 1.80B | 6.00B | 10.55B |
| SG&A Expenses | 1.55B | 1.45B | 1.29B | 1.17B | 1.13B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 11.09B | 11.79B | 10.14B | 10.23B | 9.84B |
| Operating Income | -4.24B | -2.67B | 513.00M | 4.83B | 9.42B |
| Income Before Tax | -3.94B | -2.36B | 818.00M | 5.04B | 9.58B |
| Income Tax Expenses | 772.00M | 1.11B | -389.00M | 257.00M | 1.21B |
| Earnings from Continuing Operations | -4.71K | -3.47K | 1.21K | 4.78K | 8.36K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.71B | -3.47B | 1.21B | 4.78B | 8.36B |
| EBIT | -4.24B | -2.67B | 513.00M | 4.83B | 9.42B |
| EBITDA | -3.62B | -2.17B | 876.00M | 5.17B | 9.77B |
| EPS Basic | -12.38 | -9.14 | 3.06 | 12.23 | 21.12 |
| Normalized Basic EPS | -6.34 | -3.80 | 1.30 | 8.13 | 15.15 |
| EPS Diluted | -12.42 | -9.32 | 2.74 | 11.60 | 19.99 |
| Normalized Diluted EPS | -6.33 | -3.92 | 1.09 | 7.69 | 14.32 |
| Average Basic Shares Outstanding | 1.53B | 1.53B | 1.54B | 1.56B | 1.57B |
| Average Diluted Shares Outstanding | 1.56B | 1.57B | 1.60B | 1.64B | 1.66B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
